Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 25 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 28, 2022 Filed Oct 31, 2022 17:16 UTC |
NICOLS JOHN JDirector
|
Exercise / conversionCommon Stock | 35,716 | $1.97 | $70,360.52 |
DisclosureSEC source: 0001567619-22-018951 · doc1.xml · nonDerivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 978,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 17:16 UTC |
NICOLS JOHN JDirector
|
SaleCommon Stock | 39,786 | $5.68 | $225,920.82 |
DisclosureSEC source: 0001567619-22-018951 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 943,106 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. F2 · price: This transaction was executed in multiple trades in prices ranging from $5.58 to $5.88, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 16:07 UTC |
NICOLS JOHN JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,716 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001567619-22-018358 · doc1.xml · derivative · entry 4 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,284 Underlying: Common Stock · 35,716 shares Expires 2024-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 16:07 UTC |
NICOLS JOHN JDirector
|
SaleCommon Stock | 35,716 | $5.99 | $214,099.56 |
DisclosureSEC source: 0001567619-22-018358 · doc1.xml · nonDerivative · entry 3 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,892 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. F3 · price: This transaction was executed in multiple trades in prices ranging from $5.91 to $6.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 16:07 UTC |
NICOLS JOHN JDirector
|
Exercise / conversionCommon Stock | 35,716 | $1.97 | $70,360.52 |
DisclosureSEC source: 0001567619-22-018358 · doc1.xml · nonDerivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:07 UTC |
NICOLS JOHN JDirector
|
SaleCommon Stock | 39,787 | $6.04 | $240,134.44 |
DisclosureSEC source: 0001567619-22-018358 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,892 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. F2 · price: This transaction was executed in multiple trades in prices ranging from $5.925 to $6.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:17 UTC |
Norrett KevinChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 413,405 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001567619-22-018272 · doc1.xml · derivative · entry 1 Norrett Kevin · CIK 0001819690 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,405 Underlying: Common Stock · 413,405 shares Expires 2032-10-03 F1 · derivative.exercise_date: Option vests and becomes exercisable with respect to 25% of the shares subject thereto on October 3, 2023, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on October 3, 2026, in each case, subject to continued service through the applicable vesting date. Read SEC document |
| September 28, 2022 Filed Sep 30, 2022 22:59 UTC |
Singhvi RahulDirector
|
GrantCommon Stock | 31,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-018010 · doc1.xml · nonDerivative · entry 1 Singhvi Rahul · CIK 0001322731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 F1 · shares: Restricted Stock. The shares vest as to one third of the shares on each yearly anniversary of the date of grant, provided that the Reporting Person provides continuous services to the Issuer as an employee, consultant, director or officer through each such vesting date. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:03 UTC |
NICOLS JOHN JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 39,000 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001567619-22-016368 · doc1.xml · derivative · entry 6 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,000 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:03 UTC |
NICOLS JOHN JDirector
|
SaleCommon Stock | 39,000 | $8.78 | $342,579.90 |
DisclosureSEC source: 0001567619-22-016368 · doc1.xml · nonDerivative · entry 4 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,679 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. F3 · price: This transaction was executed in multiple trades in prices ranging from $8.66 to $9.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 16:03 UTC |
NICOLS JOHN JDirector
|
Exercise / conversionCommon Stock | 39,000 | $2.32 | $90,480.00 |
DisclosureSEC source: 0001567619-22-016368 · doc1.xml · nonDerivative · entry 3 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 16:03 UTC |
NICOLS JOHN JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 38,500 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001567619-22-016368 · doc1.xml · derivative · entry 5 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 38,500 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 16:03 UTC |
NICOLS JOHN JDirector
|
SaleCommon Stock | 38,500 | $8.62 | $331,773.75 |
DisclosureSEC source: 0001567619-22-016368 · doc1.xml · nonDerivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,679 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. F2 · price: This transaction was executed in multiple trades in prices ranging from $8.32 to $8.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 16:03 UTC |
NICOLS JOHN JDirector
|
Exercise / conversionCommon Stock | 38,500 | $2.32 | $89,320.00 |
DisclosureSEC source: 0001567619-22-016368 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 22:25 UTC |
DILLY STEPHEN GEORGEDirector · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 700,000 | $0.00 Strike: $6.73 | $0.00 |
DisclosureSEC source: 0001567619-22-014899 · doc1.xml · derivative · entry 1 DILLY STEPHEN GEORGE · CIK 0001389147 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2032-08-01 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on August 1, 2023, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on August 1, 2026. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:11 UTC |
Smith David VDirector
|
GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012973 · doc1.xml · nonDerivative · entry 3 Smith David V · CIK 0001229447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,273 F3 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:11 UTC |
Smith David VDirector
|
GiftCommon Stock | 4,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012973 · doc1.xml · nonDerivative · entry 1 Smith David V · CIK 0001229447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: On June 14, 2022, the reporting person transferred 4,796 shares of the Issuer's common stock to a family trust of which the reporting person is trustee. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 16:12 UTC |
WOLF DENNIS PDirector
|
GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012974 · doc1.xml · nonDerivative · entry 1 WOLF DENNIS P · CIK 0001227560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,198 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:14 UTC |
DILLY STEPHEN GEORGEDirector
|
GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012978 · doc1.xml · nonDerivative · entry 1 DILLY STEPHEN GEORGE · CIK 0001389147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,974 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:14 UTC |
Yang Patrick YDirector
|
GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012977 · doc1.xml · nonDerivative · entry 1 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,785 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:13 UTC |
Aaker JenniferDirector
|
GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012976 · doc1.xml · nonDerivative · entry 1 Aaker Jennifer · CIK 0001820693 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,609 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:13 UTC |
Martinborough EstherDirector
|
GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012975 · doc1.xml · nonDerivative · entry 1 Martinborough Esther · CIK 0001842383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,331 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:10 UTC |
Dorgan Byron LDirector
|
GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012971 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,859 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:10 UTC |
MOORE ALISONDirector
|
GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012970 · doc1.xml · nonDerivative · entry 1 MOORE ALISON · CIK 0001754937 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,974 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:13 UTC |
Dorgan Byron LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.62 | $0.00 |
DisclosureSEC source: 0001567619-22-011827 · doc1.xml · derivative · entry 2 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:13 UTC |
Dorgan Byron LDirector
|
Exercise / conversionCommon Stock | 20,000 | $3.62 | $72,400.00 |
DisclosureSEC source: 0001567619-22-011827 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2022 Filed May 13, 2022 16:04 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 38,500 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001567619-22-010516 · doc1.xml · derivative · entry 7 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 38,500 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| May 12, 2022 Filed May 13, 2022 16:04 UTC |
NICOLS JOHN JDirector · President and CEO
|
SaleCommon Stock | 16,409 | $10.61 | $174,178.25 |
DisclosureSEC source: 0001567619-22-010516 · doc1.xml · nonDerivative · entry 5 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,679 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. F4 · price: This transaction was executed in multiple trades in prices ranging from $10.47 to $10.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| May 12, 2022 Filed May 13, 2022 16:04 UTC |
NICOLS JOHN JDirector · President and CEO
|
SaleCommon Stock | 22,091 | $10.09 | $222,942.37 |
DisclosureSEC source: 0001567619-22-010516 · doc1.xml · nonDerivative · entry 4 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,039,088 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. F3 · price: This transaction was executed in multiple trades in prices ranging from $9.47 to $10.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| May 12, 2022 Filed May 13, 2022 16:04 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionCommon Stock | 38,500 | $2.32 | $89,320.00 |
DisclosureSEC source: 0001567619-22-010516 · doc1.xml · nonDerivative · entry 3 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| May 11, 2022 Filed May 13, 2022 16:04 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 38,500 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001567619-22-010516 · doc1.xml · derivative · entry 6 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,000 Underlying: Common Stock · 38,500 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| May 11, 2022 Filed May 13, 2022 16:04 UTC |
NICOLS JOHN JDirector · President and CEO
|
SaleCommon Stock | 38,500 | $10.31 | $396,754.05 |
DisclosureSEC source: 0001567619-22-010516 · doc1.xml · nonDerivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,679 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. F2 · price: This transaction was executed in multiple trades in prices ranging from $10.07 to $10.59, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| May 11, 2022 Filed May 13, 2022 16:04 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionCommon Stock | 38,500 | $2.32 | $89,320.00 |
DisclosureSEC source: 0001567619-22-010516 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 16:08 UTC |
WOLF DENNIS PDirector
|
SaleCommon Stock | 4,000 | $20.49 | $81,944.40 |
DisclosureSEC source: 0001567619-22-007532 · doc1.xml · nonDerivative · entry 1 WOLF DENNIS P · CIK 0001227560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,925 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple trades in prices ranging from $20.17 to $20.89, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 20:05 UTC |
Yang Patrick YDirector
|
SaleCommon Stock | 8,000 | $16.79 | $134,304.80 |
DisclosureSEC source: 0001567619-22-007047 · doc1.xml · nonDerivative · entry 1 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,512 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2021. F2 · price: The shares were sold in multiple transactions at per share prices ranging from $16.474 to $17.13. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 17:43 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 38,500 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001567619-22-006782 · doc1.xml · derivative · entry 6 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,500 Underlying: Common Stock · 38,500 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 17:43 UTC |
NICOLS JOHN JDirector · President and CEO
|
SaleCommon Stock | 38,500 | $18.93 | $728,716.45 |
DisclosureSEC source: 0001567619-22-006782 · doc1.xml · nonDerivative · entry 4 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,679 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. F3 · price: This transaction was executed in multiple trades in prices ranging from $18.69 to $19.26, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 17:43 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionCommon Stock | 38,500 | $2.32 | $89,320.00 |
DisclosureSEC source: 0001567619-22-006782 · doc1.xml · nonDerivative · entry 3 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 17:43 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 38,500 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001567619-22-006782 · doc1.xml · derivative · entry 5 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,000 Underlying: Common Stock · 38,500 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 17:43 UTC |
NICOLS JOHN JDirector · President and CEO
|
SaleCommon Stock | 38,500 | $19.30 | $743,007.65 |
DisclosureSEC source: 0001567619-22-006782 · doc1.xml · nonDerivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,679 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. F2 · price: This transaction was executed in multiple trades in prices ranging from $18.71 to $19.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 17:43 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionCommon Stock | 38,500 | $2.32 | $89,320.00 |
DisclosureSEC source: 0001567619-22-006782 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. Read SEC document |
| March 05, 2022 Filed Mar 8, 2022 16:08 UTC |
TAYLOR DEAN ROSS JRSVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 2,414 | $19.30 | $46,590.20 |
DisclosureSEC source: 0001567619-22-006522 · doc1.xml · nonDerivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,778 F1 · kind: Shares withheld by the Issuer on vesting of performance stock units solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the vesting of the Reporting Person's performance stock units. Read SEC document |
| March 05, 2022 Filed Mar 8, 2022 16:08 UTC |
TAYLOR DEAN ROSS JRSVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 2,013 | $19.30 | $38,850.90 |
DisclosureSEC source: 0001567619-22-006522 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,192 F1 · kind: Shares withheld by the Issuer on vesting of performance stock units solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the vesting of the Reporting Person's performance stock units. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 21:42 UTC |
TAYLOR DEAN ROSS JRSVP, Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,006 | $0.00 Strike: $26.16 | $0.00 |
DisclosureSEC source: 0001567619-22-003128 · doc1.xml · derivative · entry 3 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,006 Underlying: Common Stock · 16,006 shares Expires 2031-02-16 F3 · shares: On February 16, 2021, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021 with any remaining shares forfeited. On February 8, 2022, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 72.75% of the target level, which will result in the vesting of the option with respect to 8,003 shares on March 5, 2022 and 8,003 shares on March 5, 2023, in each case subject to the reporting person's continued service to the issuer through such vesting date. F3 · derivative.exercise_date: On February 16, 2021, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021 with any remaining shares forfeited. On February 8, 2022, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 72.75% of the target level, which will result in the vesting of the option with respect to 8,003 shares on March 5, 2022 and 8,003 shares on March 5, 2023, in each case subject to the reporting person's continued service to the issuer through such vesting date. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 21:42 UTC |
TAYLOR DEAN ROSS JRSVP, Chief Financial Officer
|
GrantCommon Stock | 11,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-003128 · doc1.xml · nonDerivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,205 F2 · kind: Represent shares of common stock issuable pursuant to performance stock units for which achievement has been certified by the Issuer's compensation committee. Shares will be issued in two equal installments on each of March 5, 2022 and March 5, 2023, subject to continued employment through such date. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 21:41 UTC |
NICOLS JOHN JDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 200,062 | $0.00 Strike: $26.16 | $0.00 |
DisclosureSEC source: 0001567619-22-003127 · doc1.xml · derivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,062 Underlying: Common Stock · 200,062 shares Expires 2031-02-16 F1 · shares: On February 16, 2021, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021 with any remaining shares forfeited. On February 8, 2022, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 72.75% of the target level, which will result in the vesting of the option with respect to 100,031 shares on March 5, 2022 and 100,031 shares on March 5, 2023, in each case subject to the reporting person's continued service to the issuer through such vesting date. F1 · derivative.exercise_date: On February 16, 2021, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021 with any remaining shares forfeited. On February 8, 2022, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 72.75% of the target level, which will result in the vesting of the option with respect to 100,031 shares on March 5, 2022 and 100,031 shares on March 5, 2023, in each case subject to the reporting person's continued service to the issuer through such vesting date. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:42 UTC |
TAYLOR DEAN ROSS JRSVP, Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001567619-22-003128 · doc1.xml · derivative · entry 4 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2032-02-07 F4 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 7, 2023, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 7, 2026. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:42 UTC |
TAYLOR DEAN ROSS JRSVP, Chief Financial Officer
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-003128 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,205 F1 · shares: Restricted Stock Units ("RSUs") vest 1/3 annually from February 7, 2022 such that the RSUs will be fully vested on February 7, 2025. Each RSU represents a contingent right to receive one share of Codexis common stock. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:41 UTC |
NICOLS JOHN JDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001567619-22-003127 · doc1.xml · derivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-07 F2 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 7, 2023, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 7, 2026. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 16:28 UTC |
WOLF DENNIS PDirector
|
SaleCommon Stock | 2,404 | $29.27 | $70,353.54 |
DisclosureSEC source: 0001567619-21-022399 · doc1.xml · nonDerivative · entry 2 WOLF DENNIS P · CIK 0001227560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,925 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: This transaction was executed in multiple trades in prices ranging from $28.99 to $29.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.